85 related articles for article (PubMed ID: 21081217)
1. Regulation of endothelial cell tetrahydrobiopterin pathophysiological and therapeutic implications.
Harrison DG; Chen W; Dikalov S; Li L
Adv Pharmacol; 2010; 60():107-32. PubMed ID: 21081217
[TBL] [Abstract][Full Text] [Related]
2. Role of human GTP cyclohydrolase I and its regulatory protein in tetrahydrobiopterin metabolism.
Gesierich A; Niroomand F; Tiefenbacher CP
Basic Res Cardiol; 2003 Mar; 98(2):69-75. PubMed ID: 12607127
[TBL] [Abstract][Full Text] [Related]
3. GTP cyclohydrolase I phosphorylation and interaction with GTP cyclohydrolase feedback regulatory protein provide novel regulation of endothelial tetrahydrobiopterin and nitric oxide.
Li L; Rezvan A; Salerno JC; Husain A; Kwon K; Jo H; Harrison DG; Chen W
Circ Res; 2010 Feb; 106(2):328-36. PubMed ID: 19926872
[TBL] [Abstract][Full Text] [Related]
4. Redox function of tetrahydrobiopterin and effect of L-arginine on oxygen binding in endothelial nitric oxide synthase.
Berka V; Yeh HC; Gao D; Kiran F; Tsai AL
Biochemistry; 2004 Oct; 43(41):13137-48. PubMed ID: 15476407
[TBL] [Abstract][Full Text] [Related]
5. Regulation of tetrahydrobiopterin synthesis and bioavailability in endothelial cells.
Shi W; Meininger CJ; Haynes TE; Hatakeyama K; Wu G
Cell Biochem Biophys; 2004; 41(3):415-34. PubMed ID: 15509890
[TBL] [Abstract][Full Text] [Related]
6. Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function.
Milstien S; Katusic Z
Biochem Biophys Res Commun; 1999 Oct; 263(3):681-4. PubMed ID: 10512739
[TBL] [Abstract][Full Text] [Related]
7. Over-expression of GTP-cyclohydrolase 1 feedback regulatory protein attenuates LPS and cytokine-stimulated nitric oxide production.
Nandi M; Kelly P; Vallance P; Leiper J
Vasc Med; 2008 Feb; 13(1):29-36. PubMed ID: 18372436
[TBL] [Abstract][Full Text] [Related]
8. Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes.
Thum T; Fraccarollo D; Schultheiss M; Froese S; Galuppo P; Widder JD; Tsikas D; Ertl G; Bauersachs J
Diabetes; 2007 Mar; 56(3):666-74. PubMed ID: 17327434
[TBL] [Abstract][Full Text] [Related]
9. Changes in tetrahydrobiopterin levels in endothelial cells and adult cardiomyocytes induced by LPS and hydrogen peroxide--a role for GFRP?
Kalivendi S; Hatakeyama K; Whitsett J; Konorev E; Kalyanaraman B; Vásquez-Vivar J
Free Radic Biol Med; 2005 Feb; 38(4):481-91. PubMed ID: 15649650
[TBL] [Abstract][Full Text] [Related]
10. Ratio of 5,6,7,8-tetrahydrobiopterin to 7,8-dihydrobiopterin in endothelial cells determines glucose-elicited changes in NO vs. superoxide production by eNOS.
Crabtree MJ; Smith CL; Lam G; Goligorsky MS; Gross SS
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1530-40. PubMed ID: 18192221
[TBL] [Abstract][Full Text] [Related]
11. Reductive activation of Cr(Vi) by nitric oxide synthase.
Porter R; Jáchymová M; Martásek P; Kalyanaraman B; Vásquez-Vivar J
Chem Res Toxicol; 2005 May; 18(5):834-43. PubMed ID: 15892577
[TBL] [Abstract][Full Text] [Related]
12. C-Reactive protein-induced endothelial microparticle generation in HUVECs is related to BH4-dependent NO formation.
Wang JM; Wang Y; Huang JY; Yang Z; Chen L; Wang LC; Tang AL; Lou ZF; Tao J
J Vasc Res; 2007; 44(3):241-8. PubMed ID: 17351328
[TBL] [Abstract][Full Text] [Related]
13. Effect of tetrahydrobiopterin on selective endothelial dysfunction of epicardial porcine coronary arteries induced by cardiopulmonary bypass.
Stevens LM; Fortier S; Aubin MC; El-Hamamsy I; Maltais S; Carrier M; Perrault LP
Eur J Cardiothorac Surg; 2006 Sep; 30(3):464-71. PubMed ID: 16884906
[TBL] [Abstract][Full Text] [Related]
14. Potential therapeutic applications of tetrahydrobiopterin: from inherited hyperphenylalaninemia to mitochondrial diseases.
Kim HK; Ha SH; Han J
Ann N Y Acad Sci; 2010 Jul; 1201():177-82. PubMed ID: 20649554
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of V-1 prevents nitric oxide-induced cell death: involvement of enhanced tetrahydrobiopterin biosynthesis.
Yuyama K; Yamamoto H; Nakamura K; Nishizaki I; Yamakuni T; Song SY; Sora I; Nagatsu T; Yamamoto T
J Neurosci Res; 2003 Jun; 72(6):716-25. PubMed ID: 12774312
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
[TBL] [Abstract][Full Text] [Related]
17. Human endothelial dihydrofolate reductase low activity limits vascular tetrahydrobiopterin recycling.
Whitsett J; Rangel Filho A; Sethumadhavan S; Celinska J; Widlansky M; Vasquez-Vivar J
Free Radic Biol Med; 2013 Oct; 63():143-50. PubMed ID: 23707606
[TBL] [Abstract][Full Text] [Related]
18. Two modes of binding of N-hydroxyguanidines to NO synthases: first evidence for the formation of iron-N-hydroxyguanidine complexes and key role of tetrahydrobiopterin in determining the binding mode.
Lefèvre-Groboillot D; Frapart Y; Desbois A; Zimmermann JL; Boucher JL; Gorren AC; Mayer B; Stuehr DJ; Mansuy D
Biochemistry; 2003 Apr; 42(13):3858-67. PubMed ID: 12667076
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease.
Schmidt TS; Alp NJ
Clin Sci (Lond); 2007 Jul; 113(2):47-63. PubMed ID: 17555404
[TBL] [Abstract][Full Text] [Related]
20. A novel high-throughput screening assay for discovery of molecules that increase cellular tetrahydrobiopterin.
Li L; Du Y; Chen W; Fu H; Harrison DG
J Biomol Screen; 2011 Sep; 16(8):836-44. PubMed ID: 21693765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
